Euroz Hartleys Analysis | Commercial Day Webinar
Euroz Hartleys’ Seth Lizee reviews the Botanix Commercial Day Webinar and maintains a Speculative Buy recommendation with an upgraded $0.33 Price Target.
Lizee expressed increased confidence in the late June FDA approval decision and BOT’s commercial strategy.
